Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Lazarowski

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Frontiers in Behavioral Neuroscience|April 8, 2020
Cannabidiol (CBD) Inhibited Rhodamine-123 Efflux in Cultured Vascular Endothelial Cells and Astrocytes Under Hypoxic ConditionsJerónimo Auzmendi, Pablo Palestro, Agustín Blachman, et al.
Frontiers in Bioscience (Elite Edition)|June 5, 2014
Pharmacoresistant epilepsy and nanotechnologyArgelia Rosillo-de la Torre, Gabriel Luna-Bárcenas, Sandra Orozco-Suárez, et al.
Neuroscience Letters|January 24, 2007
Nimodipine restores the altered hippocampal phenytoin pharmacokinetics in a refractory epileptic modelChristian Höcht, Alberto Lazarowski, Nélida N Gonzalez, et al.
Frontiers in Bioscience (Landmark Edition)|November 5, 2016
Role of JNK isoforms in the kainic acid experimental model of epilepsy and neurodegenerationCarme Auladell, Luisa de Lemos, Ester Verdaguer, et al.
Frontiers in Pharmacology|May 19, 2023
Editorial: Pharmacogenetics and pharmacogenomics in Latin America: ethnic variability, new insights in advances and perspectives: a RELIVAF-CYTED initiative, Volume IIAndrés López-Cortés, Patricia Esperón, Matías F Martínez, et al.
Expert Review of Neurotherapeutics|May 12, 2015
Masitinib for the treatment of mild to moderate Alzheimer's diseaseJaume Folch, Dmitry Petrov, Miren Ettcheto, et al.
Journal of Alzheimer'S Disease : JAD|June 7, 2021
Translational Research and Drug Discovery for Neurodegeneration: Challenges for Latin AmericaK S Jagannatha Rao, Gabrielle B Britton, Luisa Lilia Rocha Arrieta, et al.
Expert Opinion on Investigational Drugs|June 25, 2014
Mavoglurant as a treatment for Parkinson's diseaseDmitry Petrov, Ignacio Pedros, Maria Luisa de Lemos, et al.
Epilepsy & Behavior : E&B|August 18, 2019
New anticonvulsant candidates prevent P-glycoprotein (P-gp) overexpression in a pharmacoresistant seizure model in miceAndrea Verónica Enrique, Mauricio Emiliano Di Ianni, Sofía Goicoechea, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|October 10, 2015
Combinational Effect of CYP3A5 and MDR-1 Polymorphisms on Tacrolimus Pharmacokinetics in Liver Transplant PatientsJefferson Antonio Buendía, Esteban Otamendi, María Cecilia Kravetz, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Frontiers in Behavioral Neuroscience|April 8, 2020
Cannabidiol (CBD) Inhibited Rhodamine-123 Efflux in Cultured Vascular Endothelial Cells and Astrocytes Under Hypoxic ConditionsJerónimo Auzmendi, Pablo Palestro, Agustín Blachman, et al.
Frontiers in Bioscience (Elite Edition)|June 5, 2014
Pharmacoresistant epilepsy and nanotechnologyArgelia Rosillo-de la Torre, Gabriel Luna-Bárcenas, Sandra Orozco-Suárez, et al.
Neuroscience Letters|January 24, 2007
Nimodipine restores the altered hippocampal phenytoin pharmacokinetics in a refractory epileptic modelChristian Höcht, Alberto Lazarowski, Nélida N Gonzalez, et al.
Frontiers in Bioscience (Landmark Edition)|November 5, 2016
Role of JNK isoforms in the kainic acid experimental model of epilepsy and neurodegenerationCarme Auladell, Luisa de Lemos, Ester Verdaguer, et al.
Frontiers in Pharmacology|May 19, 2023
Editorial: Pharmacogenetics and pharmacogenomics in Latin America: ethnic variability, new insights in advances and perspectives: a RELIVAF-CYTED initiative, Volume IIAndrés López-Cortés, Patricia Esperón, Matías F Martínez, et al.
Expert Review of Neurotherapeutics|May 12, 2015
Masitinib for the treatment of mild to moderate Alzheimer's diseaseJaume Folch, Dmitry Petrov, Miren Ettcheto, et al.
Journal of Alzheimer'S Disease : JAD|June 7, 2021
Translational Research and Drug Discovery for Neurodegeneration: Challenges for Latin AmericaK S Jagannatha Rao, Gabrielle B Britton, Luisa Lilia Rocha Arrieta, et al.
Expert Opinion on Investigational Drugs|June 25, 2014
Mavoglurant as a treatment for Parkinson's diseaseDmitry Petrov, Ignacio Pedros, Maria Luisa de Lemos, et al.
Epilepsy & Behavior : E&B|August 18, 2019
New anticonvulsant candidates prevent P-glycoprotein (P-gp) overexpression in a pharmacoresistant seizure model in miceAndrea Verónica Enrique, Mauricio Emiliano Di Ianni, Sofía Goicoechea, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|October 10, 2015
Combinational Effect of CYP3A5 and MDR-1 Polymorphisms on Tacrolimus Pharmacokinetics in Liver Transplant PatientsJefferson Antonio Buendía, Esteban Otamendi, María Cecilia Kravetz, et al.
Pageof 6